Pranay D. Khare

Medicine · Health Sciences

10h-index867citations37works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(18), Phagocytosis and Immune Regulation(9), Immunotherapy and Immune Responses(7), Virus-based gene therapy research(7), Monoclonal and Polyclonal Antibodies Research(6)

Publications36 total

Supplemental Figure 3 from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases
2023Open Access
Supplemental Figure 1 from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases
2023Open Access
Data from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases
2023Open Access
Supplemental Figure 3 from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases
2023Open Access
Supplemental Figure 4 from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases
2023Open Access
Supplemental Figure 2 from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases
2023Open Access
Supplemental Figure 1 from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases
2023Open Access
Supplemental Figure 4 from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases
2023Open Access
Supplemental Figure 2 from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases
2023Open Access
Data from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases
2023Open Access
Abstract P005: GEN-011: A neoantigen-targeted peripheral blood-derived T cell therapy that has broad neoantigen specificity and high T cell purity while avoiding pro-tumor T cells
Cancer Immunology Research·2022
Expanded ATLAS™-identified neoantigen-specific peripheral T cells (NPTs) demonstrate considerable neoantigen breadth, polyfunctionality, and effector function
The Journal of Immunology·2021
149 GEN-011: An ATLAS<sup>TM</sup>-guided peripheral-blood derived neoantigen-specific T cell therapy designed to improve on TIL approaches
Regular and Young Investigator Award Abstracts·2020Open Access
Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
Cancer Gene Therapy·2018· 97 citedOpen Access
CD19-Specific Chimeric Antigen Receptor-Modified T Cells with Safety Switch Produced Under “Point-of-Care” Using the Sleeping Beauty System for the Very Rapid Manufacture and Treatment of B-Cell Malignancies
Blood·2017· 6 cited
IMMU-33. CONTROLLED LOCAL EXPRESSION OF IL-12 AS GENE THERAPY CONCOMITANT WITH SYSTEMIC CHEMOTHERAPY IMPROVES SURVIVAL IN GLIOMA
Neuro-Oncology·2017Open Access
IMMU-34. CONTROLLED EXPRESSION OF IL-12 IMPROVES SURVIVAL IN GLIOMA BY ACTIVATING THE IMMUNE RESPONSE IN MICE AND HUMANS
Neuro-Oncology·2017Open Access
Analysis, Design and Estimation of G +7 Storey Building Structure by using IS Code Methods and by Software's
International Journal of Engineering and Management Research·2017· 2 citedOpen Access
Focusing on Induced Virtual Water
International Journal of Engineering and Applied Sciences (IJEAS)·2016Open Access
Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma
Aesthetic Surgery Journal·2016· 155 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Steven C. Katz(12), Rachel A. Burga(12), Elise McCormack(12), Mitchell Thorn(12), Brian F. Stainken(12), Earle O. Assanah(12), N. Joseph Espat(12), Richard P. Junghans(12), Wesley Mooring(11), Gary R. Point(11), Qiangzhong Ma(11), Lijuan Wang(10), Robin Davies(10), Nils A. Loewen(5), John Barrett(4), Tim Hon Man Chan(4), Laurence J.N. Cooper(4), Hongliang Cai(3), John Miao(3), François Lebel(3)